# SGM-101 Tumor Targeted Fluorescence Endoscopy in Rectal Polyps With Suspected T1 Adenocarcinoma or High Grade Dysplasia

> **NCT06280690** · PHASE2 · UNKNOWN · sponsor: **Leiden University Medical Center** · enrollment: 20 (estimated)

## Conditions studied

- Colorectal Cancer
- Image
- Low Grade Dysplasia of Colon

## Interventions

- **DRUG:** SGM-101

## Key facts

- **NCT ID:** NCT06280690
- **Lead sponsor:** Leiden University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-01-31
- **Primary completion:** 2025-04-30
- **Final completion:** 2025-07-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-02-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06280690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06280690, "SGM-101 Tumor Targeted Fluorescence Endoscopy in Rectal Polyps With Suspected T1 Adenocarcinoma or High Grade Dysplasia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06280690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*